Ansa Biotechnologies
PrivateLast Round
Series B
Oct 1, 2025
Total Funding Raised
$132.59M
Momentum Score
25 /100
Company Overview
Ansa Biotechnologies is a biotechnology company that offers a groundbreaking DNA synthesis technology aimed at streamlining the biological research process through highly accurate gene-length oligonucleotide synthesis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ansa Biotechnologies Comps
Public and private peers based on sector, stage, and business model.
Ansa Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 1, 2025 | ||||
| Series A | Apr 11, 2022 | ||||
| Grant | Apr 15, 2021 | ||||
| Seed | Sep 1, 2020 | ||||
| Pre Seed | Dec 1, 2018 |
Key People
Founding team and executive leadership
Ansa Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Seed, Series A |
| RA Capital Management | Series A |
| Fall Line Capital | Series B |
| Codon Capital | Series A |
| Altitude Life Science Ventures | Series A, Series B |
| Carbon Silicon Ventures | Series A |
| PEAK6 Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Will present at SynBioBeta 2026 conference in San Jose, CA.
- Mar 31, 2026
Matthias Arenskötter appointed as the new COO.
Ansa Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ansa Biotechnologies's valuation, stock price, and market status.
